Shares of Venus Treatments Ltd rose 1% to hit a day’s excessive of Rs 361.95 on twenty second Could after the corporate mentioned it had renewed its GMP (Good Manufacturing Practices) certification from Ukraine’s regulatory physique for its Unit-II facility in Baddi.
The certification was granted by Ukraine’s State Service on Medicines and Medication Management (SMDC), serving to strengthen Venus Treatments’ world presence.
Ukraine is a member of the Pharmaceutical Inspection Cooperation Scheme (PlC/S), which incorporates 56 international locations. This enhances the worldwide credibility of Venus Treatments’ manufacturing practices.
The pharmaceutical market in Ukraine is projected to develop at a CAGR of three.9% and attain $822.26 million by 2029, pushed by demand for generics and oncology medication.
Venus mentioned its licensed Baddi Unit-II plant has superior infrastructure to fulfill complicated therapeutic calls for and align with world healthcare wants.
Firm officers famous that the GMP renewal boosts their presence in Ukraine and helps develop additional into different PlC/S member markets.
At 1:45 PM, the shares of Venus Treatments had been buying and selling 0.70% larger at Rs 352.35 on NSE.
Bought Venus Treatments-Associated Questions? The Analyst is Prepared.
Prepared to take a position like a professional? Unicorn Alerts app equips you with 100+ Free instruments and data it’s essential succeed. Obtain the Unicorn Alerts app and acquire entry to each day inventory lists and insightful market evaluation and way more!
